Literature DB >> 24979569

Gradenigo's syndrome as first presentation of solitary osseous plasmacytoma of the petrous apex.

Mahmoud Reza Khalatbari1, Mehrdokht Hamidi2, Yashar Moharamzad3.   

Abstract

Plasma cell tumors of the skull base are rare in neurosurgical practice. True solitary osseous plasmacytoma of the skull base without development of multiple myeloma is extremely rare. We report a case of typical Gradenigo's syndrome, including left abducens nerve palsy, left facial pain and paresthesia in V1 and V2 distribution of trigeminal nerve caused by solitary osseous plasmacytoma of the left petrous apex. The patient was a 46-year-old man who presented with diplopia for two days. Magnetic resonance imaging (MRI) of the brain showed a hyperintense mass on T1-weighted images and slightly hypointense mass on T2-weighted images in the left petrous apex and left parasellar area. Through a left subtemporal middle fossa approach, subtotal resection of the lesion was performed. Histopathological examination of the lesion revealed plasmacytoma. The patient received 54 Gy radiation for the local tumor. Four months after radiation, the abducens palsy improved. Four years after treatment, the patient remained well with no symptoms or signs of local recurrence or progression to multiple myeloma.

Entities:  

Mesh:

Year:  2014        PMID: 24979569     DOI: 0141707/AIM.0016

Source DB:  PubMed          Journal:  Arch Iran Med        ISSN: 1029-2977            Impact factor:   1.354


  2 in total

1.  Short-term therapeutic effects of low-dose cytarabine plus surgical resection on elderly patients with trigeminal nerve tumor and safety observation.

Authors:  Xiang-Sheng Li; Wei-Long Yang; Fa-Zheng Shen; Guo-Jun Gao; Ji-Wei Ma; Bao-Zhe Jin
Journal:  Pak J Med Sci       Date:  2015 Jan-Feb       Impact factor: 1.088

2.  Steroid-Responsive Gradenigo's Syndrome Mimicking Subdural Hematoma.

Authors:  Yi Liu; Po-Kuan Yeh; Yu-Pang Lin; Yueh-Feng Sung
Journal:  Cureus       Date:  2021-11-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.